Search research articles
Contact Us
Filters
Showing results (91-100 of 109) with videos related to
Page
of 11
Sort By:
European Urology
|
April 21, 2023
Bone Biomarkers and Subsequent Survival in Men with Hormone-sensitive Prostate Cancer: Results from the SWOG S1216 Phase 3 Trial of Androgen Deprivation Therapy with or Without Orteronel
Primo N Lara, Edward Mayerson, Erik Gertz, et al.
JAMA Network Open
|
July 9, 2024
Bone Pain and Survival Among Patients With Metastatic, Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the SWOG-1216 Trial
Georges Gebrael, Yeonjung Jo, Umang Swami, et al.
The Journal of Urology
|
January 16, 2007
Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes
Michael S Cookson, Gunnar Aus, Arthur L Burnett, et al.
The Journal of Urology
|
May 19, 2007
Guideline for the management of clinically localized prostate cancer: 2007 update
Ian Thompson, James Brantley Thrasher, Gunnar Aus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 12, 2014
Can urinary PCA3 supplement PSA in the early detection of prostate cancer?
John T Wei, Ziding Feng, Alan W Partin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2024
Radiographic Progression-Free Survival and Clinical Progression-Free Survival as Potential Surrogates for Overall Survival in Men With Metastatic Hormone-Sensitive Prostate Cancer
Susan Halabi, Akash Roy, Larysa Rydzewska, et al.
The Journal of Urology
|
June 16, 2007
Erectile function outcome reporting after clinically localized prostate cancer treatment
Arthur L Burnett, Gunnar Aus, Edith D Canby-Hagino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 14, 2024
Reply to J.A. Garcia et al
Susan Halabi, Siyuan Guo, Akash Roy, et al.
JAMA Network Open
|
October 7, 2024
Circulating Tumor Cell Count and Overall Survival in Patients With Metastatic Hormone-Sensitive Prostate Cancer
Amir Goldkorn, Catherine Tangen, Melissa Plets, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 26, 2015
CD14++CD16+ Monocytes Are Enriched by Glucocorticoid Treatment and Are Functionally Attenuated in Driving Effector T Cell Responses
Baoying Liu, Ashwin Dhanda, Sima Hirani, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 109) with videos related to
Sort By:
Page
of 11
European Urology
|
April 21, 2023
Bone Biomarkers and Subsequent Survival in Men with Hormone-sensitive Prostate Cancer: Results from the SWOG S1216 Phase 3 Trial of Androgen Deprivation Therapy with or Without Orteronel
Primo N Lara, Edward Mayerson, Erik Gertz, et al.
JAMA Network Open
|
July 9, 2024
Bone Pain and Survival Among Patients With Metastatic, Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the SWOG-1216 Trial
Georges Gebrael, Yeonjung Jo, Umang Swami, et al.
The Journal of Urology
|
January 16, 2007
Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes
Michael S Cookson, Gunnar Aus, Arthur L Burnett, et al.
The Journal of Urology
|
May 19, 2007
Guideline for the management of clinically localized prostate cancer: 2007 update
Ian Thompson, James Brantley Thrasher, Gunnar Aus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 12, 2014
Can urinary PCA3 supplement PSA in the early detection of prostate cancer?
John T Wei, Ziding Feng, Alan W Partin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2024
Radiographic Progression-Free Survival and Clinical Progression-Free Survival as Potential Surrogates for Overall Survival in Men With Metastatic Hormone-Sensitive Prostate Cancer
Susan Halabi, Akash Roy, Larysa Rydzewska, et al.
The Journal of Urology
|
June 16, 2007
Erectile function outcome reporting after clinically localized prostate cancer treatment
Arthur L Burnett, Gunnar Aus, Edith D Canby-Hagino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 14, 2024
Reply to J.A. Garcia et al
Susan Halabi, Siyuan Guo, Akash Roy, et al.
JAMA Network Open
|
October 7, 2024
Circulating Tumor Cell Count and Overall Survival in Patients With Metastatic Hormone-Sensitive Prostate Cancer
Amir Goldkorn, Catherine Tangen, Melissa Plets, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 26, 2015
CD14++CD16+ Monocytes Are Enriched by Glucocorticoid Treatment and Are Functionally Attenuated in Driving Effector T Cell Responses
Baoying Liu, Ashwin Dhanda, Sima Hirani, et al.
Page
of 11